Christi shares about her
lung cancer diagnosis journey and the initial treatments she received. Later when it was discovered that her lung cancer had progressed to stage 4, she had
comprehensive biomarker testing which revealed she has the
EGFR exon 19 deletion lung cancer mutation. It is recommended that biomarker testing happen immediately following diagnosis to determine the best treatment for each patient's unique cancer.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.